Sciclone Pharmaceuticals

Sciclone Pharmaceuticals is a company listed under the stock ticker SCLN (HK).

View the org chart displaying its 15 main executives

Most searched biographies at Sciclone Pharmaceuticals

• Hong Zhao, President and Chief Executive Officer
• Daniel Luzius Vasella, Director
• Zhenfu Li, Chairman of the Board

Create your alert
to follow the executive moves at Sciclone Pharmaceuticals.

Sciclone Pharmaceuticals has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Sciclone Pharmaceuticals

Social media about Sciclone Pharmaceuticals

• Sciclone Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Sciclone Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Hong Zhao

Call Sciclone Pharmaceuticals at +1 650...

View the org chart

Register to receive your alert

Report an error